Investing Ideas
/
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies

Danish Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

5 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
HLUN B H. Lundbeck	DKK 39.48	-8.9%	16.3%	DKK 37.8b	DKK 51.68	PE12.5x	E6.5%	2.4%
GMAB Genmab	DKK 1,587.50	6.5%	-20.5%	DKK 100.9b	DKK 2,201.81	PE12.9x	E13.9%	n/a
BAVA Bavarian Nordic	DKK 173.75	0.5%	-0.06%	DKK 13.5b	DKK 279.00	PE12.1x	E-0.4%	n/a
HLUN A H. Lundbeck	DKK 32.60	-5.6%	8.0%	DKK 37.8b	DKK 42.68	PE12.5x	E6.5%	2.4%
NOVO B Novo Nordisk	DKK 595.30	5.2%	-30.2%	DKK 2.6t	DKK 813.17	PE26.2x	E12.9%	1.9%

Page 1 of 1